# An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

> **NCT02537015** · PHASE2 · COMPLETED · sponsor: **ForSight Vision5, Inc.** · enrollment: 81 (actual)

## Conditions studied

- Primary Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost

## Key facts

- **NCT ID:** NCT02537015
- **Lead sponsor:** ForSight Vision5, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-10
- **Primary completion:** 2016-08-11
- **Final completion:** 2016-08-11
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02537015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02537015, "An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02537015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*